⌘K

Rallybio Corporation (RLYB)

$1.11 0.91% $0.01 Healthcare

Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; and RLYB116, a subcutaneously administered inhibitor of C5 for the treatment of patients with paroxysmal nocturnal hemoglobinuria and generalized myasthenia gravis. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.

Market cap

$46.05M

CEO

Dr. Martin W. MacKay Ph.D.

Full time employees

44.00

Headquarters

New Haven, CT

IPO Date

Jul 29, 2021

Price-to-earnings (PE) Ratio

-0.62

Earnings-per-share (EPS)

$-1.78

Cash ratio (TTM)

4.04

Current ratio (TTM)

18.23

Net profit margin (TTM)

0.00%

PE ratio (TTM)

-1.44

Price-to-book ratio (TTM)

0.70

Price-to-sales ratio (TTM)

0.00

Quick ratio (TTM)

17.12

Return on assets (TTM)

-45.55%

Return on equity (TTM)

-45.14%

Similar stocks (11)

Edgewise Therapeutics, Inc.

EWTX

$28.44 49.20% $9.38

Uptrend

Cullinan Oncology, Inc.

CGEM

$17.56 1.89% $0.32

Downtrend

Third Harmonic Bio, Inc.

THRD

$14.46 7.11% $0.96

Uptrend

Eliem Therapeutics, Inc.

ELYM

$8.51 6.64% $0.53

Uptrend

C4 Therapeutics, Inc.

CCCC

$6.97 9.23% $0.59

Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$6.22 4.63% $0.28

Neutral

PepGen Inc.

PEPG

$9.98 7.78% $0.72

Downtrend

Century Therapeutics, Inc.

IPSC

$1.76 6.71% $0.11

Downtrend

MediciNova, Inc.

MNOV

$1.68 8.06% $0.12

Neutral

PMV Pharmaceuticals, Inc.

PMVP

$1.54 1.66% $0.02

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.06 0.00% $0.00

Downtrend

ETF Exposure (11)

iShares Micro-Cap ETF

IWC

0.00688%

$126.54 2.19% $2.71

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.50 1.86% $5.16

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$183.01 2.05% $3.67

Uptrend

Downtrend

Similar stocks (11)

Edgewise Therapeutics, Inc.

EWTX

$28.44 49.20% $9.38

Uptrend

Cullinan Oncology, Inc.

CGEM

$17.56 1.89% $0.32

Downtrend

Third Harmonic Bio, Inc.

THRD

$14.46 7.11% $0.96

Uptrend

Eliem Therapeutics, Inc.

ELYM

$8.51 6.64% $0.53

Uptrend

C4 Therapeutics, Inc.

CCCC

$6.97 9.23% $0.59

Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$6.22 4.63% $0.28

Neutral

PepGen Inc.

PEPG

$9.98 7.78% $0.72

Downtrend

Century Therapeutics, Inc.

IPSC

$1.76 6.71% $0.11

Downtrend

MediciNova, Inc.

MNOV

$1.68 8.06% $0.12

Neutral

PMV Pharmaceuticals, Inc.

PMVP

$1.54 1.66% $0.02

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.06 0.00% $0.00

Downtrend

ETF Exposure (11)

iShares Micro-Cap ETF

IWC

0.00688%

$126.54 2.19% $2.71

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.50 1.86% $5.16

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$183.01 2.05% $3.67

Uptrend